Affordable Care Act to Assist Texas Medical Research Associates in Clinical Trials

Share Article

Experts say the U.S. Supreme Court’s upholding of the individual mandate will benefit biomedical research. Since the Affordable Care Act just went into effect in January 2014, researchers will now see the benefits of the mandate upheld by the U.S. Supreme Court.

Texas Medical Research Associates, a clinical research facility, say that the Affordable Care Act, in effect as of Jan. 1, 2014, will have a positive impact on biomedical research.

The U.S. Supreme Court upheld the ACA’s individual mandate by a vote of 5-4 on June 28, 2012. The ACA contains provisions that will establish a pathway for the Food and Drug Administration to approve generic version of protein-based drugs, often referred to as biosimilars. The ACA also creates a research initiative at the National Institutes of Health called the Cures Acceleration Network, the launch of the Physician Payment Sunshine Act, and a push to increase funding for comparative effectiveness research. The Physician Payment Sunshine Act would require pharmaceutical and device makers to disclose all payments of more than $10 made to doctors.

“With this ruling, what we have is the turning of a page and a new chapter,” said Mary Wooley, CEO of science advocacy group Research!America. “It is time to be talking about research and innovation as a major driver in health care.”

To read more, please visit

Texas Medical Research Associates believes clinical trials are an integral part of the healthcare system. They allow drug companies and research organizations like them to look into new treatment options and ensure the treatments are safe and effective before approval for use in the general public. They currently have several studies that are in need of participants. For more information, please visit their website at, or call 210-521-7771.

About the Company:

Texas Medical Research Associates is a full-service clinical research site adjacent to Dr. Patrick H. Peters' internal medicine practice. TMR exists to aid in the development of new medical treatments, vaccines, and devices. Adhering strictly to GCP/ICH guidelines and FDA regulations, they strive to ensure the safety of our research subjects while meeting the needs of their sponsors.

They are committed to supporting the community and regularly conduct free health screenings across greater San Antonio. Through outreach events like these, they promote the importance of clinical research to the general public and identify health needs in individuals who otherwise might not receive adequate healthcare.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Andrea Pena
Visit website